These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35534883)

  • 1. The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial.
    Li YQ; Shen TT; Wang QY; Ma MX; Tian FY; She YY; Tao YC; Wang JJ; Chi HY; Lang N; Ren JX
    Trials; 2022 May; 23(1):379. PubMed ID: 35534883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of So-Cheong-Ryong-Tang in patients with atopic dermatitis and respiratory disorders: Study protocol of a double-blind randomized placebo-controlled trial.
    Kang SJ; Cho HB; Jo EH; Yang GJ; Hong JE; Lee JH; Shim YH; Mun JH; Park MC
    Medicine (Baltimore); 2020 Jan; 99(2):e18565. PubMed ID: 31914034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Soshiho-tang in atopic dermatitis patients with gastrointestinal disorders: A double-blinded, randomized, and placebo-controlled clinical trial.
    Lee JH; Jo EH; Jung JY; Kang SJ; Yang GJ; Shim YH; Park MC
    J Ethnopharmacol; 2021 Jun; 274():114006. PubMed ID: 33766759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Soshiho-tang in patients with atopic dermatitis and gastrointestinal disorders: Study protocol for a double-blind, randomized, and placebo-controlled clinical trial.
    Kang SJ; Jo EH; Yang GJ; Shim YH; Hong JE; Park MC
    Medicine (Baltimore); 2019 May; 98(18):e15479. PubMed ID: 31045830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial.
    Xuan M; Guo X; Li H; Xie T; Mo X; Wen Z
    Trials; 2021 Jan; 22(1):67. PubMed ID: 33468222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trial.
    Gu SX; Zhang AL; Coyle ME; Mo X; Lenon GB; Cranswick NE; Chen D; Xue CC
    Trials; 2015 Jul; 16():294. PubMed ID: 26149448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of Jaungo in atopic dermatitis patients: study protocol for a randomized, controlled trial.
    Yun Y; Ko Y; Ahn JH; Jang BH; Kim K; Ko SG; Choi I
    Trials; 2017 Apr; 18(1):176. PubMed ID: 28403910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Bojungikgi-tang on anorexic patients with atopic dermatitis: A protocol for a randomized, usual care-controlled, assessor-blinded, parallel, pilot clinical trial.
    Lee B; Park HJ; Jung SY; Kwon OJ; Ko MM; Jeong HA; Jung J
    Medicine (Baltimore); 2022 Mar; 101(9):e28965. PubMed ID: 35244061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of an herbal formula, Gwakhyangjeonggi-san on atopic dermatitis with gastrointestinal symptoms: Protocol for a randomized controlled trial.
    Son MJ; Kim MH; Kang M; Kim YE; Jung J; Choi I
    Medicine (Baltimore); 2020 Jul; 99(28):e20675. PubMed ID: 32664064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Chinese herbal medicine for the treatment of atopic dermatitis: a randomised controlled study.
    Liu J; Mo X; Wu D; Ou A; Xue S; Liu C; Li H; Wen Z; Chen D
    Complement Ther Med; 2015 Oct; 23(5):644-51. PubMed ID: 26365443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics analysis of Gwakhyangjeonggi-san for gastrointestinal complications in atopic dermatitis: A randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
    Ko MM; Shin S; Kim MH; Kang M; Baek MG; Yi H; Son MJ; Jung J
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117256. PubMed ID: 37778520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
    Chan S; Cornelius V; Cro S; Harper JI; Lack G
    JAMA Pediatr; 2020 Jan; 174(1):29-37. PubMed ID: 31764962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.
    Shen Z; Zheng K; Zou J; Gu P; Xing J; Zhang L; Zhu L; Shen H
    Trials; 2021 Jan; 22(1):55. PubMed ID: 33441157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and safety of a Chinese herbal formula (RCM-106) for atopic dermatitis: study protocol for a randomised, double-blind, placebo-controlled trial in children.
    Tan HY; Zhang AL; Xue CC; Chen D; Da Costa C; Lenon GB
    BMJ Open; 2013 Dec; 3(12):e003906. PubMed ID: 24381256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial.
    Chan S; Cornelius V; Chen T; Radulovic S; Wan M; Jahan R; Lack G
    Trials; 2017 Mar; 18(1):136. PubMed ID: 28330497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study.
    Ahn JH; Yun Y; Kim MH; Ko SG; Kim KS; Choi I
    Complement Ther Med; 2018 Oct; 40():22-28. PubMed ID: 30219454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial).
    Totté J; de Wit J; Pardo L; Schuren F; van Doorn M; Pasmans S
    Trials; 2017 Aug; 18(1):404. PubMed ID: 28859690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blinded, placebo-controlled randomized trial evaluating the efficacy and safety of Zhigancao Tang granules for treating HFpEF: study protocol for a randomized controlled trial.
    Zhang N; Zhao Y; Liu Y; Tang N; Zheng W; Mao M; Liu Q; Shen L; Deng B
    Trials; 2021 Apr; 22(1):293. PubMed ID: 33879223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial.
    Luo Q; Zhou S; Li X; Chen Q; Lin W; Lu L; Li H; Chen C; Chen W; Li Y
    Trials; 2019 Jan; 20(1):66. PubMed ID: 30658660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.